| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Robbins Wendye is a Director at RAPT Therapeutics, Inc.. Recent SEC Form 4 filings include 36 buys and 0 sells.
Estimated insider holdings value: $261K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2023 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 5,000 | $19.52 | $97,612.00 | +11.2% | +4.5% | -56.4% | |
| May 10, 2022 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 7,000 | $11.04 | $77,282.00 | +23.0% | +95.7% | +77.4% | |
| Oct 18, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 500 | $30.70 | $15,350.00 | +5.7% | -21.5% | -27.3% | |
| Oct 13, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 400 | $29.69 | $11,876.00 | +4.8% | +9.3% | -26.3% | |
| Aug 24, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 2,000 | $31.28 | $62,564.95 | +32.3% | +3.4% | -8.0% | |
| Aug 20, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 600 | $29.53 | $17,716.50 | +3.8% | +18.3% | -10.9% | |
| Jul 7, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 1,000 | $30.18 | $30,180.00 | +7.0% | -2.9% | -34.9% | |
| Jun 16, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 705 | $31.54 | $22,237.04 | +3.6% | +16.2% | -54.3% | |
| Apr 13, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 700 | $19.46 | $13,620.00 | +6.3% | +72.0% | +13.9% | |
| Apr 9, 2021 | RAPT Rapt Therapeutics, Inc. | Director | Buy | 1,400 | $21.07 | $29,504.87 | +4.5% | +60.2% | +12.0% |